Arcutis Biotherapeutics Inc
NASDAQ:ARQT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Arcutis Biotherapeutics Inc
NASDAQ:ARQT
|
US |
|
A
|
ALM Equity AB
STO:ALM
|
SE |
|
CapitaLand Ascott Trust
SGX:HMN
|
SG |
|
R
|
RMK Energy PT Tbk
IDX:RMKE
|
ID |
|
CorMedix Inc
NASDAQ:CRMD
|
US |
|
U
|
United Plantations Bhd
KLSE:UTDPLT
|
MY |
|
Renova Inc
TSE:9519
|
JP |
|
H
|
Heritage Global Inc
NASDAQ:HGBL
|
US |
|
Forvia SE
PAR:FRVIA
|
FR |
|
Lintec Corp
TSE:7966
|
JP |
|
I-Mab
NASDAQ:NBP
|
US |
|
Dermata Therapeutics Inc
NASDAQ:DRMA
|
US |
|
V
|
Vodacom Group Ltd
JSE:VOD
|
ZA |
|
Arwana Citramulia Tbk PT
IDX:ARNA
|
ID |
|
W
|
Wasco Bhd
KLSE:WASCO
|
MY |
Bankruptcy Probability
Arcutis Biotherapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Arcutis Biotherapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Arcutis Biotherapeutics Inc
NASDAQ:ARQT
|
2.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
381.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Arcutis Biotherapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Arcutis Biotherapeutics Inc has total debt of 101.5m USD. This includes both short-term (0 USD) and long-term (101.5m USD) debt.
You can find a full breakdown on its Balance Sheet.
